Shortcast 2 When should pharma companies start looking at workflow automation Feature

Shortcast Episode 2: When Should Pharma Companies Start Looking at Workflow Automation?

 

The clinical supply chain is critical to the success of any trial. Yet managing it is often more complicated than it should be. Many organizations still rely on a patchwork of legacy systems, Excel, SharePoint, and email to coordinate activities and transfer data. As demand for clinical supplies increases, these disconnected processes create risks – missed releases, delays in trials, and in the worst cases, an impact on patients.

In this shortcast, Pramod Sachdeva explores why clinical supply chain management is so challenging today and how Process Automation is emerging as a powerful solution. He discusses the risks of limited visibility across siloed systems, and why having no single source of truth leaves organizations vulnerable to inefficiencies and errors.

Pramod also highlights how Process Automation can bring order to the complexity, by orchestrating data across systems, streamlining collaboration, and ensuring tasks are assigned, tracked, and completed with full transparency. The result? Greater efficiency, better visibility, and stronger alignment across the supply chain.

If you’ve experienced the frustrations of managing clinical supplies with disconnected tools, this shortcast is a quick listen that offers fresh perspective on how automation can simplify, standardize, and strengthen one of the most vital processes in life sciences.

See how Merck Optimizes its Clinical Supply Chain

By Combining workflow automation and data integration across the clinical supply chain, Merck improves transparency, accountability, and the quality review and release process. (Co-presented by Merck, Princeton Blue and Appian at the SCOPE 2023 Conference.)

Scroll to Top